Insider Trading Money in eBay, Oracle, Gilead Sciences, Johnson & Johnson, Schlumberger, and VeriFone
HONG KONG, Sept. 9, 2013 /PRNewswire/ -- Pennystocksinsiders.com (PSI) released insider trading reports for investors to track the following active stocks and penny stocks: eBay (NASDAQ: EBAY), Oracle (NYSE: ORCL), Gilead Sciences (NASDAQ: GILD), Johnson & Johnson (NYSE: JNJ), Schlumberger (NYSE: SLB), and VeriFone (NYSE: PAY).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
eBay Inc (NASDAQ: EBAY): By the end of last trading session, the shares of eBay (NASDAQ: EBAY) earned 1.69% (or US$0.88) to US$52.83 with 12.07 million shares exchanged hands, compared to its average daily volume 8.45 million shares. Pennystocksinsiders.com found company SVP, Legal Affairs, GC & Sec, Michael R. Jacobson, sold his shares at a price of US$51.15 for about US$1.56 million on August 29. The company acquired Decide.com, which provided online shopping research service that predicted whether prices were going up or down on consumer electronics, housewares and other products. Pennystocksinsiders.com thinks that it is a clever way to check if insiders like CEOs, CFOs, and Directors in eBay are starting to buy or sell more company shares. Check this insider trade report for EBAY here.
Read Full Report: http://www.Pennystocksinsiders.com/PR/090913A/EBAY/eBay.pdf
Oracle Corporation (NYSE: ORCL): By the end of last trading session, the Oracle (NYSE: ORCL) shares lost 0.19% (or US$0.06) to US$32.20 with about 12.63 million shares exchanged hands for the session, compared to its average volume of 16.30 million shares. Pennystocksinsiders.com found company President, Mark V. Hurd, sold his shares at a price of US$32.23 for about US$16.11 million on September 3. In fiscal 2013, the technical giant spent US$4.9 billion, or 13% of revenue, on research and development to enhance their products and services. Want to track the company insiders in Oracle are starting to buy or sell more company shares? See insider trade report for ORCL here.
Read Full Report: http://www.Pennystocksinsiders.com/PR/090913A/ORCL/Oracle.pdf
Gilead Sciences, Inc. (NASDAQ: GILD): By the end of last trading, the Gilead Sciences (NASDAQ: GILD) shares earned US$0.05 (or 0.08%) to US$61.12 with about 8.28 million shares exchanged hands for the session, compared to its average volume of 7.40 million shares. Pennystocksinsiders.com found company Chairman and CEO, John C. Martin, sold his shares at a price of US$60.97 for about US$17.21 million on September 3. Want to know when company insiders will buy or sell their shares? Want to monitor this company on an on-going basis?
Read Full Report: http://www.Pennystocksinsiders.com/PR/090913A/GILD/GileadSciences.pdf
Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may be involved in trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Johnson & Johnson (NYSE: JNJ):
Read Full Report: http://www.Pennystocksinsiders.com/PR/090913A/JNJ/JohnsonJohnson.pdf
Schlumberger Limited. (NYSE: SLB):
Read Full Report: http://www.Pennystocksinsiders.com/PR/090913A/SLB/Schlumberger.pdf
VeriFone Systems Inc (NYSE: PAY):
Read Full Report: http://www.Pennystocksinsiders.com/PR/090913A/PAY/VeriFone.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit Pennystocksinsiders.com/disclaimers/index.php for details.
More by this Source
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.